Cefpodoxime Proxetil Induced Oral Ulcer Case Series

Published on:April 2022
Indian Journal of Pharmacy Practice, 2022; 15(2):155-157
Case Report | doi:10.5530/ijopp.15.2.28


Cefpodoxime Proxetil Induced Oral Ulcer Case Series


Authors and affiliation (s):

Mahek Mistry*, Jitin Raghunathan Nair*, Riki Kamleshbhai Patel, Ashish Karn, Bhavya Kalpesh Modi

Department of Pharmacy, Sumandeep Vidyapeeth (Deemed to be University), Piparia, Waghodia, Vadodara, Gujarat, INDIA.

Abstract:

Cefpodoxime Proxetil is an extended spectrum cephalosporin of third generation. It inhibits bacterial cell wall synthesis by binding to one or more of the penicillin binding proteins. We came across two cases for getting oral ulcers after administering Cefpodoxime Proxetil 200 mg which was prescribed for viral fever. We suspected adverse drug reaction as per the temporal relationship. After reviewing previous literatures and database (e.g. Micromedex, UpToDate.) we found that oral ulcers are not proved as an adverse reaction due to Cefpodoxime Proxetil. These rare cases mainly occur due to lack of rapid diagnostic tools, which can concomitantly cause antibiotic resistance in patients and can be a public threat in near future. After prescribing such drugs monitoring of patient is required to prevent any harmful effects. Clinical Pharmacist can play vital role in this field of healthcare.

Keywords: Antibiotic Resistance, Cephalosporin, Cefpodoxime Proxetil, Oral ulcer, Adverse Drug Reaction.




 

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.

DOI HISTORY

IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs